Klow Blend: Four-Peptide Research Formulation Guide (GHK-Cu, BPC-157, TB-500, KPV)

What Is the Klow Blend?

Klow Blend is a lyophilized four-peptide research formulation combining GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) in a single 80mg vial. Researchers studying multi-pathway interventions in preclinical models use this type of combination formulation to examine whether synergistic activity is achievable across these overlapping systems.

Component Research Overview

GHK-Cu (Copper Peptide) — 50mg

BPC-157 (Body Protection Compound) — 10mg

BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric protein sequence.

TB-500 (Thymosin Beta-4 Analog) — 10mg

TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide involved in actin regulation and cell motility.

KPV (Lys-Pro-Val) — 10mg

KPV is a tripeptide fragment (Lys-Pro-Val) derived from the C-terminal sequence of alpha-melanocyte stimulating hormone (α-MSH).

Rationale for Four-Component Combination

Because the Klow Blend contains four components at fixed ratios, researchers work with the combined 80mg total when calculating molarity or mg/mL concentration — not the individual peptide masses.

Frequently Asked Questions

What is Klow Blend used for in research?

The blend allows researchers to study the combined activity of these peptides in a single formulation.

How does Klow Blend differ from BPC-157 and TB-500 alone?

This creates a four-pathway model not covered by the BPC-157/TB-500 pairing alone.

What is KPV and why is it included in Klow Blend?

KPV (Lys-Pro-Val) is a tripeptide derived from alpha-MSH.

Is there clinical data on the Klow Blend combination?

No human clinical trial data exists for the Klow Blend as a combined formulation. Each individual component has its own preclinical data profile. GHK-Cu and BPC-157 have the most extensive preclinical literature; TB-500 and KPV have more limited but growing research bases. All research on Klow Blend and its components remains at the preclinical stage.

Research-Grade Klow Blend at Loti Labs

Loti Labs supplies Klow Blend 80mg — a four-peptide research formulation combining GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg — for preclinical and in vitro laboratory research. Each batch is independently verified by third-party HPLC analysis. Supplied for research use only.